Attys Want 33% Slice Of $1M Pie In PolyMedix Stock Suit
The lead plaintiff in an investor class action against now-bankrupt experimental drug company PolyMedix Inc. asked a Pennsylvania federal judge on Monday to approve a $1.15 million settlement with nearly $400,000...To view the full article, register now.
Already a subscriber? Click here to view full article